New blood tests could speed up detection of deadly fungal infections

NCT ID NCT07422155

Completed Diagnosis Sponsor: Institute of Oncology Ljubljana Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether combining several blood tests can detect serious fungal infections (candidemia) faster and more accurately than standard methods. Researchers tested 2 hospitalized adults with suspected fungal infections using both routine blood cultures and newer tests like PCR and specific biomarkers. The goal was to see if these extra tests help doctors diagnose and treat infections earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Candida Diagnostic Testing Panel (blood tests including beta-D-glucan, mannan, anti-mannan antibodies, and PCR)
What this could lead to: If successful, this could lead to faster and more accurate diagnosis of serious fungal infections, helping doctors start the right treatment sooner.
What could go wrong: This was a very small study with only 2 participants, so results may not apply to larger groups. The tests may not be widely available or affordable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANDIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

candidemia candidiasis, invasive disseminated candidiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANDIDEMIA INVASIVE CANDIDIASIS

Contacts and locations

Locations

Institute of Oncology Ljubljana

Ljubljana, 1000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.